Optimizing human embryonic stem cells differentiation efficiency by screening size-tunable homogenous embryoid bodies

Biomaterials

Volumn 35, Issue 23, 2014, Pages 5987-5997

  Moon, Sung Hwan ^a   Ju, Jongil ^b   Park, Soon Jung ^a   Bae, Daekyeong ^c   Chung, Hyung Min ^a   Lee, Sang Hoon ^b  

^a Konkuk University School of Medicine   (South Korea)

^b Korea University   (South Korea)

^c CHA Stem Cell Institute   (South Korea)

Author keywords

Concave microwells; Embryoid body; Human embryonic stem cell; Optimize differentiation; Size screening

Indexed keywords

CELL GROWTH; ENDOTHELIAL CELLS;

CELL DIFFERENTIATION; CELL-CELL CONTACT; EMBRYOID BODY; GROWTH FACTOR; HUMAN EMBRYONIC STEM CELLS; MICROWELLS; PHYSICAL ENVIRONMENTS; SPHERICAL STRUCTURES;

OPTIMIZATION;

BONE MORPHOGENETIC PROTEIN 4; CD31 ANTIGEN; GROWTH FACTOR; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG;

ARTICLE; CELL AGGREGATION; CELL DIFFERENTIATION; CELL LINEAGE; CELL STRUCTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; EMBRYOID BODY; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; MESODERM; MICROWELL PLATE; PARTICLE SIZE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SCREENING; BIOREACTOR; CELL LINE; CELL SEPARATION; CLASSIFICATION; CYTOLOGY; DEVICE FAILURE ANALYSIS; DEVICES; EQUIPMENT DESIGN; MICROFLUIDICS; PHYSIOLOGY; PROCEDURES;

BIOREACTORS; CELL LINE; CELL SEPARATION; EMBRYOID BODIES; EMBRYONIC STEM CELLS; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; HUMANS; MICROFLUIDICS;

EID: 84900020561     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.04.001     Document Type: Article

References (31)

1. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., et al. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
2. Gepstein L. Derivation and potential applications of human embryonic stem cells. Circ Res 2002, 91:866-876.
3. Chapin R., Augustine-Rauch K., Beyer B., Daston G., Finnell R., Flynn T., et al. State of the art in developmental toxicity screening methods and a way forward: a meeting report addressing embryonic stem cells, whole embryo culture, and zebrafish. Birth Defects Res B Dev Reprod Toxicol 2008, 83:446-456.
4. Mummery C.L., Zhang J., Ng E.S., Elliott D.A., Elefanty A.G., Kamp T.J. Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ Res 2012, 111:344-358.
5. Metallo C.M., Azarin S.M., Ji L., de Pablo J.J., Palecek S.P. Engineering tissue from human embryonic stem cells. JCell Mol Med 2008, 12:709-729.
6. Watanabe K., Ueno M., Kamiya D., Nishiyama A., Matsumura M., Wataya T., et al. AROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol 2007, 25:681-686.
7. Murry C.E., Keller G. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 2008, 132:661-680.
8. Kim J.M., Moon S.H., Lee S.G., Cho Y.J., Hong K.S., Lee J.H., et al. Assessment of differentiation aspects by the morphological classification of embryoid bodies derived from human embryonic stem cells. Stem Cells Dev 2011, 20:1925-1935.
9. Moon S.H., Kim S.W., Kim J.S., Park S.J., Do J.T., Lee D.R., et al. Gene expression profiles in CHA3 and CHA4 human embryonic stem cells and embryoid bodies. Mol Cells 2011, 31:315-326.
10. Keller G.M. Invitro differentiation of embryonic stem cells. Curr Opin Cell Biol 1995, 7:862-869.
11. Zweigerdt R., Burg M., Willbold E., Abts H., Ruediger M. Generation of confluent cardiomyocyte monolayers derived from embryonic stem cells in suspension: a cell source for new therapies and screening strategies. Cytotherapy 2003, 5:399-413.
12. Karp J.M., Yeh J., Eng G., Fukuda J., Blumling J., Suh K.Y., et al. Controlling size, shape and homogeneity of embryoid bodies using poly(ethylene glycol) microwells. Lab Chip 2007, 7:786-794.
13. Khademhosseini A., Yeh J., Eng G., Karp J., Kaji H., Borenstein J., et al. Cell docking inside microwells within reversibly sealed microfluidic channels for fabricating multiphenotype cell arrays. Lab Chip 2005, 5:1380-1386.
14. Peerani R., Rao B.M., Bauwens C., Yin T., Wood G.A., Nagy A., et al. Niche-mediated control of human embryonic stem cell self-renewal and differentiation. EMBO J 2007, 26:4744-4755.
15. Zandstra P.W., Nagy A. Stem cell bioengineering. Annu Rev Biomed Eng 2001, 3:275-305.
16. Cameron C.M., Hu W.S., Kaufman D.S. Improved development of human embryonic stem cell-derived embryoid bodies by stirred vessel cultivation. Biotechnol Bioeng 2006, 94:938-948.
17. Zhang Y., Xia Y. Formation of embryoid bodies with controlled sizes and maintained pluripotency in three-dimensional inverse opal scaffolds. Adv Funct Mater 2012, 22:121-129.
18. Bauwens C.L., Song H., Thavandiran N., Ungrin M., Masse S., Nanthakumar K., et al. Geometric control of cardiomyogenic induction in human pluripotent stem cells. Tissue Eng Part A 2011, 17:1901-1909.
19. Wong S.F., No da Y., Choi Y.Y., Kim D.S., Chung B.G., Lee S.H. Concave microwell based size-controllable hepatosphere as a three-dimensional liver tissue model. Biomaterials 2011, 32:8087-8096.
20. Choi Y.Y., Chung B.G., Lee D.H., Khademhosseini A., Kim J.H., Lee S.H. Controlled-size embryoid body formation in concave microwell arrays. Biomaterials 2010, 31:4296-4303.
21. Adewumi O., Aflatoonian B., Ahrlund-Richter L., Amit M., Andrews P.W., Beighton G., et al. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol 2007, 25:803-816.
22. Jeong G.S., Song J.H., Kang A.R., Jun Y., Kim J.H., Chang J.Y., et al. Surface tension-mediated, concave-microwell arrays for large-scale, simultaneous production of homogeneously sized embryoid bodies. Adv Healthc Mater 2013, 2:119-125.
23. Lee S.A., No da Y., Kang E., Ju J., Kim D.S., Lee S.H. Spheroid-based three-dimensional liver-on-a-chip to investigate hepatocyte-hepatic stellate cell interactions and flow effects. Lab Chip 2013, 13:3529-3537.
24. Goldman O., Feraud O., Boyer-Di Ponio J., Driancourt C., Clay D., Le Bousse-Kerdiles M.C., et al. Aboost of BMP4 accelerates the commitment of human embryonic stem cells to the endothelial lineage. Stem Cells 2009, 27:1750-1759.
25. Chadwick K., Wang L., Li L., Menendez P., Murdoch B., Rouleau A., et al. Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood 2003, 102:906-915.
26. Bai H., Gao Y., Arzigian M., Wojchowski D.M., Wu W.S., Wang Z.Z. BMP4 regulates vascular progenitor development in human embryonic stem cells through a Smad-dependent pathway. JCell Biochem 2010, 109:363-374.
27. Moon S.H., Kim J.S., Park S.J., Lee H.J., Do J.T., Chung H.M. Asystem for treating ischemic disease using human embryonic stem cell-derived endothelial cells without direct incorporation. Biomaterials 2011, 32:6445-6455.
28. Bibikova M., Chudin E., Wu B., Zhou L., Garcia E.W., Liu Y., et al. Human embryonic stem cells have a unique epigenetic signature. Genome Res 2006, 16:1075-1083.
29. Kim J.M., Moon S.H., Park S.J., Lee H.Y., Hong K.S., Seo J., et al. Pertussis toxin enhances colony organization of enzymatic-dissociated single human embryonic stem cells. Stem Cells Dev 2013, 22:307-319.
30. Hwang Y.S., Chung B.G., Ortmann D., Hattori N., Moeller H.C., Khademhosseini A. Microwell-mediated control of embryoid body size regulates embryonic stem cell fate via differential expression of WNT5a and WNT11. Proc Natl Acad Sci U S A 2009, 106:16978-16983.
31. Valamehr B., Jonas S.J., Polleux J., Qiao R., Guo S., Gschweng E.H., et al. Hydrophobic surfaces for enhanced differentiation of embryonic stem cell-derived embryoid bodies. Proc Natl Acad Sci U S A 2008, 105:14459-14464.